🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of acetaminophen, claiming the firms concealed alleged dangers that the pain reliever presented to pediatric brain development.

The court filing follows a month after President Donald Trump publicized an unsubstantiated connection between taking Tylenol - also known as paracetamol - while pregnant and autism in young ones.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever approved for pregnant women, and Kenvue, which presently makes it.

In a declaration, he said they "misled consumers by profiting off of pain and promoting medication ignoring the potential hazards."

The manufacturer says there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to line their pockets," the attorney general, a Republican, stated.

The company commented that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the health of women and children in America."

On its online platform, the company also said it had "continuously evaluated the applicable studies and there is insufficient valid information that shows a proven link between consuming acetaminophen and autism."

Organizations representing medical professionals and healthcare providers agree.

The leading OB-GYN organization has said paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to address discomfort and fever, which can create significant medical dangers if ignored.

"In more than two decades of investigation on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the use of paracetamol in any stage of pregnancy causes neurodevelopmental disorders in children," the group stated.

The court filing mentions latest statements from the previous government in asserting the drug is reportedly hazardous.

In recent weeks, the former president caused concern from health experts when he told pregnant women to "struggle intensely" not to use acetaminophen when ill.

The US Food and Drug Administration then published an announcement that physicians should consider limiting the usage of acetaminophen, while also declaring that "a causal relationship" between the drug and autism in young ones has not been proven.

Health Secretary Kennedy, who oversees the FDA, had promised in spring to initiate "a massive testing and research effort" that would identify the cause of autism in a limited time.

But authorities cautioned that discovering a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complex mix of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a form of permanent neurological difference and condition that impacts how people perceive and interact with the world, and is recognized using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

The lawsuit seeks to make the firms "remove any commercial messaging" that claims acetaminophen is reliable for pregnant women.

This legal action parallels the complaints of a assembly of guardians of young ones with autism and ADHD who sued the manufacturers of Tylenol in 2022.

A federal judge threw out the lawsuit, saying studies from the parents' expert witnesses was not conclusive.